Vanguard Group Inc Neogenomics Inc Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NEO
# of Institutions
282Shares Held
128MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$270 Million0.01% of portfolio
-
Brown Advisory Inc9.67MShares$131 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$93.1 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$85.3 Million0.06% of portfolio
-
State Street Corp Boston, MA4.9MShares$66.5 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.71B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...